Zydus Lifesciences Ltd.
BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
901.95
10.40
(1.17%)
< Home
< Back
Zydus Lifesciences Ltd. News
>>
Zydus Lifesciences gains as its arm inks pact with PRG S&T to license molecule for HGPS
>>
Zydus Lifesciences’ arm inks pact with PRG S&T to license molecule for HGPS
>>
Zydus Lifesciences’ Desidustat tablets secure approval for renal anaemia in China
>>
Zydus Lifesciences gets final nod for Cevimeline Hydrochloride Capsules
>>
Zydus Lifesciences to launch continuous Glucose Monitoring devices Diasens, GlucoLive
>>
Zydus Lifesciences gets USFDA’s approval for Ivermectin Tablets, Dapsone Tablets
>>
Zydus Lifesciences submits press release
>>
Zydus Lifesciences climbs on planning to launch Semaglutide injection in India
>>
Zydus Lifesciences to launch Semaglutide injection in India
>>
USFDA concludes Pre-Approval inspection at Zydus Lifesciences’ Ahmedabad facility
<<
<
1
2
3
...168
>
>>